LOS ANGELES, Nov. 3, 2025 /PRNewswire/ — The DJS Law Group reminds investors of a class action lawsuit against Tronox Holdings plc (“Tronox” or “the Company”) (NYSE: TROX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders… Continue reading Tronox Holdings plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – TROX
Tag: Financial Results
bp unlocks value, divests non-controlling interests in US onshore midstream assets for $1.5 billion
bp divests non-controlling interests in Permian and Eagle Ford midstream assets to private investor Sixth Street for $1.5 billion Agreement enables bp to unlock capital from infrastructure, while retaining operatorship and control of strategic midstream assets Transaction delivers a material contribution towards bp’s 2025 expected divestment proceeds and target of $20 billion of divestments by the end… Continue reading bp unlocks value, divests non-controlling interests in US onshore midstream assets for $1.5 billion
Arctic Therapeutics Receives EMA Approval for Phase IIa Study of AT-001 in Alzheimer’s Disease
The European Medicines Agency (EMA) authorises initiation of a Phase IIa study evaluating AT-001 in patients diagnosed with Alzheimer’s disease EMA grants Orphan Drug Designation (ODD) to AT-001 for hereditary cystatin C amyloid angiopathy (HCCAA), a rare familial dementia REYKJAVÍK, Iceland, Nov. 3, 2025 /PRNewswire/ — Arctic Therapeutics (ATx), an Iceland-based clinical-stage biopharmaceutical company, today announced… Continue reading Arctic Therapeutics Receives EMA Approval for Phase IIa Study of AT-001 in Alzheimer’s Disease
Arctic Therapeutics Receives EMA Approval for Phase IIa Study of AT-001 in Alzheimer’s Disease
The European Medicines Agency (EMA) authorises initiation of a Phase IIa study evaluating AT-001 in patients diagnosed with Alzheimer’s disease EMA grants Orphan Drug Designation (ODD) to AT-001 for hereditary cystatin C amyloid angiopathy (HCCAA), a rare familial dementia REYKJAVÍK, Iceland, Nov. 3, 2025 /PRNewswire/ — Arctic Therapeutics (ATx), an Iceland-based clinical-stage biopharmaceutical company, today announced… Continue reading Arctic Therapeutics Receives EMA Approval for Phase IIa Study of AT-001 in Alzheimer’s Disease
Festive green spark: EVs hit record in October, E2W sales cross 1 million in 2025
Electric three-wheelers (excluding e-rickshaws) grew to 70,604 units, compared with 67,173 units in October 2024 and 61,044 units in September this year. This festive month of Oct proved to be nothing short of impressive for India’s electric vehicle (EV) industry. Total EV registrations reached an all-time high, with every segment of battery-powered vehicles experiencing positive… Continue reading Festive green spark: EVs hit record in October, E2W sales cross 1 million in 2025
Molina Healthcare, Inc. (MOH) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Robbins Geller Rudman & Dowd LLP
SAN DIEGO, Nov. 3, 2025 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Molina Healthcare, Inc. (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, both dates inclusive (the “Class Period”), have until Tuesday, December 2, 2025 to seek appointment as lead plaintiff of… Continue reading Molina Healthcare, Inc. (MOH) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Robbins Geller Rudman & Dowd LLP
RLX Technology to Report Third Quarter 2025 Financial Results on November 14, 2025
– Earnings Call Scheduled for 7:00 a.m. ET on November 14, 2025 – SHENZHEN, China, Nov. 3, 2025 /PRNewswire/ — RLX Technology Inc. (“RLX Technology” or the “Company”) (NYSE: RLX), a leading global branded e-vapor company, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2025, before the U.S. markets… Continue reading RLX Technology to Report Third Quarter 2025 Financial Results on November 14, 2025
VFC Investors have Opportunity to Lead V.F. Corporation Securities Fraud Lawsuit
NEW YORK, Nov. 2, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of V.F. Corporation (NYSE: VFC) between October 30, 2023 and May 20, 2025, both dates inclusive (the “Class Period”), of the important November 12, 2025 lead plaintiff deadline. So what: If you purchased V.F. Corporation… Continue reading VFC Investors have Opportunity to Lead V.F. Corporation Securities Fraud Lawsuit
GFM Services Berhad Receives Frost & Sullivan’s 2025 Malaysian Facility Management Competitive Strategy Leadership Recognition for Excellence in Innovation-Driven Operations
This recognition highlights GFM Services Berhad’s leadership in operational excellence, energy efficiency, and sustainable facility management through technology-driven solutions and governance excellence. SAN ANTONIO, Nov. 2, 2025 /PRNewswire/ — Frost & Sullivan is pleased to announce that GFM Services Berhad has been given the 2025 Malaysian Facility Management Competitive Strategy Leadership Recognition for its outstanding achievements in cost… Continue reading GFM Services Berhad Receives Frost & Sullivan’s 2025 Malaysian Facility Management Competitive Strategy Leadership Recognition for Excellence in Innovation-Driven Operations
NAVER D2SF-backed Nota AI Lists on KOSDAQ, Embarking on Global Expansion in AI Model Compression and Optimization
Successfully listed on KOSDAQ with unique competitiveness for AI lightweighting and optimization technology Driving rapid annual revenue growth through collaborations with global leaders including NVIDIA, Samsung Electronics, and Qualcomm Focusing post-IPO efforts on developing a next-generation optimization platform and expanding global markets SEOUL, South Korea, Nov. 2, 2025 /PRNewswire/ — NAVER D2SF–backed Nota AI, a… Continue reading NAVER D2SF-backed Nota AI Lists on KOSDAQ, Embarking on Global Expansion in AI Model Compression and Optimization